Evaluation Process for Buildings and Individuals with Suspected Mold Exposure

Alfred Johnson, D.O.
2016 International Summit on Mycotoxin Treatments
Plano, TX. June 3-5, 2016

Depression & Mycotoxicosis in a Female College Student

Richard G. Jaeckle, M.D., F.A.P.A., F.A.A.C.A.P., F.A.A.E.M., F.A.A.O.A.
2016 International Summit on Mycotoxin Treatments
Plano, TX. June 3-5, 2016

Treatment Approach for Chronic Mold and Mycotoxin Illness

Joseph Brewer, M.D.
2016 International Summit on Mycotoxin Treatments
Plano, TX. June 3-5, 2016

Evaluation and Treatment of Pulmonary Disease Developed After Exposure to Indoor Mold Contamination – A Case Study

Adrienne Sprouse, M.D., M.ED.
2016 International Summit on Mycotoxin Treatments
Plano, TX. June 3-5, 2016

Toxic Exposure To Molds And Mycotoxins In Building Related Illness

William Rea, M.D.
2016 International Summit on Mycotoxin Treatments
Plano, TX. June 3-5, 2016

The Secret Cause Of Disease

Gordon J. Crozier, D.O.
2016 International Summit on Mycotoxin Treatments
Plano, TX. June 3-5, 2016

Gliotoxin Presence in Patients

Joseph Brewer, M.D.
2016 International Summit on Mycotoxin Treatments
Plano, TX. June 3-5, 2016

Rationale for the Use of Liposomal Glutathione in the Management of Mycotoxin-Related Conditions

Frederick T. Guilford, M.D.
2016 International Summit on Mycotoxin Treatments
Plano, TX. June 3-5, 2016

Diagnosing Mycotoxin Related Illness and Treatment Plans Incorporating Genetic Detoxification and Methylation Pathways

Ann Shippy, M.D.
2016 International Summit on Mycotoxin Treatments
Plano, TX. June 3-5, 2016

Remediation of Mold Contaminated Structures and Treatment of the Mold Injured Individual

Alfred Johnson, D.O.
2016 International Summit on Mycotoxin Treatments
Plano, TX. June 3-5, 2016

[/restrictedarea]